epirubicin ebewe 2 mgml
novartis israel ltd - epirubicin hydrochloride - concentrate for solution for infusion - epirubicin hydrochloride 2 mg/ml - epirubicin - for the treatment of wide spectrum of neoplastic diseases including breast carcinoma, lung carcinoma (high doses), ovarian carcinoma, gastric carcinomas, soft tissue sarcoma. intravesical administration of farmorubicin has been found to be beneficial in the treatment of superficial bladder carcinomas and in the prophylaxis of recurrences after stransurethral resection. i.v. administration for the treatment of advanced bladder carcinoma.
pharmorubicin 10mg/5ml solution for injection cytosafe vials
pfizer ltd - epirubicin hydrochloride - solution for injection - 2mg/1ml
pharmorubicin 50mg/25ml solution for injection cytosafe vials
pfizer ltd - epirubicin hydrochloride - solution for injection - 2mg/1ml
pharmorubicin 200mg/100ml solution for infusion cytosafe vials
pfizer ltd - epirubicin hydrochloride - solution for infusion - 2mg/1ml
epi-cell 50 mg
mbi pharma ltd., israel - epirubicin hydrochloride - solution for injection - epirubicin hydrochloride 50 mg / 25 ml - epirubicin - for the treatment of wide spectrum of neoplastic diseases including breast carcinoma, lung carcinoma (high doses), ovarian carcinoma, gastric carcinomas, soft tissue sarcoma. intravesical administration of epirubicin has been found to be beneficial in the treatment of superficial bladder carcinomas and in the prophylaxis of recurrences after transurethral resection. i.v. administration for the treatment of advanced bladder carcinoma.
farmorubicin rapid dissolution powder lyophilized for solution for infusion
actavis italy s.p.a. - epirubicin (epirubicin hydrochloride) - powder lyophilized for solution for infusion - 50mg
farmorubicin rapid dissolution powder lyophilized for solution for infusion
actavis italy s.p.a. - epirubicin (epirubicin hydrochloride) - powder lyophilized for solution for infusion - 10mg
epirubicin teva ® 2 mg/ml
salomon,levin & elstein ltd - epirubicin hydrochloride 2 mg / 1 ml - solution for injection / infusion - epirubicin - for the treatment of wide spectrum of neoplastic diseases, including:- breast carcinoma- lung carcinoma - high doses- ovarian carcinoma- gastric carcinomas- soft tissue sarcoma- i.v. administration for the treatment of advanced bladder carcinoma- intravesical administration of epirubicin has been found to be beneficial in the treatment of superficial bladder carcinomas and in the prophylaxis of recurrences after transurethral resection.
epirubicin inovamed
inovamed ltd - epirubicin hydrochloride - solution for injection - epirubicin hydrochloride 2 mg / 1 ml - epirubicin - epirubicin - for the treatment of wide spectrum of neoplastic diseases including breast carcinoma, lung carcinoma high doses, ovarian carcinoma, gastric carcinomas, soft tissue sarcoma. intravesical administration of epirubicin has been found to be beneficial in the treatment of superficial bladder carcinomas and in the prophylaxis of recurrences after transurethral resection. i.v. administration for the treatment of advanced bladder carcinoma.
epirubicin
seacross pharmaceuticals limited - epirubicin hydrochloride - solution for injection - 2 mg/ml - epirubicin